(0.11%) 5 523.00 points
(0.14%) 39 898 points
(0.23%) 19 796 points
(-0.02%) $81.61
(0.46%) $2.82
(-0.29%) $2 337.60
(0.12%) $29.56
(0.29%) $1 004.70
(0.00%) $0.931
(-0.03%) $10.53
(-0.01%) $0.788
(-0.86%) $87.24
0.00% $ 1.350
Live Chart Being Loaded With Signals
Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD)...
Stats | |
---|---|
Dzisiejszy wolumen | 60 423 |
Średni wolumen | 22 358 |
Kapitalizacja rynkowa | 25.49M |
EPS | $-0.580 ( Q3 | 2023-11-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0960 (7.11%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-10 | Bitterman Kevin | Sell | 20 000 | Common Stock |
2024-01-10 | Atlas Venture Fund X, L.p. | Sell | 30 000 | Common Stock |
2024-01-10 | Atlas Venture Fund X, L.p. | Sell | 20 000 | Common Stock |
2023-12-29 | Quisel John D | Sell | 2 700 | Stock Option (Right to Buy) |
2023-12-29 | Quisel John D | Buy | 2 700 | Common Stock |
INSIDER POWER |
---|
-92.97 |
Last 100 transactions |
Buy: 61 440 | Sell: 1 683 907 |
Wolumen Korelacja
Gemini Therapeutics, Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Gemini Therapeutics, Inc. Korelacja - Waluta/Towar
Gemini Therapeutics, Inc. Finanse
Annual | 2022 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $0 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $0 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.667 |
FY | 2020 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.0538 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Gemini Therapeutics, Inc.
Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 for treatment of systemic diseases. Gemini Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej